SCHEMBL16448944

SCHEMBL16448944

CCCCCOC(=O)/C=C/C(=O)OCCCN1CCCCC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 3/20 0.57
ATM Q13315 1/20 0.56
THRB P10828 4/20 0.46
THRA P10827 2/20 0.46
CYP2D6 P10635 2/20 0.46
ACHE P22303 3/20 0.45
BCHE P06276 1/20 0.45
MAPT P10636 3/20 0.45
NPSR1 Q6W5P4 2/20 0.45
MAPK1 P28482 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
RAB9A P51151 1/20 0.44
LTA4H P09960 1/20 0.43
KCNH2 Q12809 2/20 0.43
HRH3 Q9Y5N1 2/20 0.43
ALDH1A1 P00352 2/20 0.43
LMNA P02545 2/20 0.43
CYP1A2 P05177 1/20 0.43
CHRM2 P08172 1/20 0.43
CHRM4 P08173 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16448950 0.97 HCAR2 (0.57) HCAR2ATMTHRBTHRACYP2D6
SCHEMBL16448952 0.95 HCAR2 (0.58) HCAR2ATMTHRBTHRAACHE
SCHEMBL16448951 0.95 ATM (0.62) HCAR2ATMTHRBTHRACYP2D6
SCHEMBL16448941 0.94 HCAR2 (0.57) HCAR2ATMTHRBTHRACYP2D6
SCHEMBL16448947 0.94 ATM (0.61) HCAR2ATMTHRBTHRACYP2D6
SCHEMBL16448945 0.92 ATM (0.53) HCAR2ATMCYP2D6ACHEBCHE
SCHEMBL16448949 0.91 ATM (0.51) HCAR2ATMCYP2D6ACHEBCHE
SCHEMBL16448943 0.89 ACHE (0.51) HCAR2ATMCYP2D6ACHEBCHE
SCHEMBL16448948 0.89 ATM (0.62) HCAR2ATMTHRBTHRACYP2D6
SCHEMBL16448946 0.88 BCHE (0.56) HCAR2ATMCYP2D6ACHEBCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8952006-B2 Morpholinoalkyl fumarate compounds, pharmaceutical compositions, and methods of use XENOPORT, INC. (US) 2015-02-10 US disclosed